维普中文期刊产品整合服务
15篇 您的检索式:作者名="Toru Aoyama"
    题名 作者 年代 出处 被引量
1Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: A retrospective study in patients undergoing primary percutaneous coronary intervention显示文摘Hideki Ishii Satoshi Ichimiya Masaaki Kanashiro Toru Aoyama Yasuhiro Ogawa Ryuichiro Murakami Tetsuya Amano Keiko Naruse Tatsuaki Matsubara Toyoaki Murohara 2006Clinical Therapeutics2006,,11:1
2Risk Factors for Peritoneal Recurrence in Stage II/III Gastric Cancer Patients Who Received S-1 Adjuvant Chemotherapy After D2 Gastrectomy显示文摘Toru Aoyama Takaki Yoshikawa Tsutomu Hayashi Hiroshi Kuwabara Yo Mikayama Takashi Ogata Haruhiko Cho Akira Tsuburaya 2012Annals of Surgical Oncology2012,,5:1
3Macroscopic tumor size as an independent prognostic factor for stage II/III gastric cancer patients who underwent D2 gastrectomy followed by adjuvant chemotherapy with S-1显示文摘Toru Aoyama Takaki Yoshikawa Takafumi Watanabe Tsutomu Hayashi Takashi Ogata Haruhiko Cho Akira Tsuburaya 2011Gastric Cancer2011,,3:1
4Laparoscopic esophagojejunostomy using the EndoStitch and a circular stapler under a direct view created by the ENDOCAMELEON显示文摘Takaki Yoshikawa Tsutomu Hayashi Toru Aoyama Haruhiko Cho Hirohito Fujikawa Junya Shirai Shinichi Hasegawa Takanobu Yamada Takashi Oshima Norio Yukawa Yasushi Rino Munetaka Masuda Takashi Ogata Akira Tsuburaya 2013Gastric Cancer2013,,4:1
5Incidence and pattern of hemolytic anemia after minor ABO-mismatched living-donor lobar lung transplantation显示文摘Akihiro Ohsumi Fengshi Chen Kimiko Yurugi Taira Maekawa Tsuyoshi Shoji Masaaki Sato Akihiro Aoyama Toru Bando Hiroshi Date 2013Surgery Today2013,,11:1
6γ-Secretase inhibitor reduces diet-induced atherosclerosis in apolipoprotein E-deficient mice显示文摘Toru Aoyama Kyosuke Takeshita Ryosuke Kikuchi Koji Yamamoto Xian Wu Cheng James K. Liao Toyoaki Murohara 2009Biochemical and Biophysical Research Communications2009,,2:1
7Pathological complete response of locally advanced gastric cancer after four courses of neoadjuvant chemotherapy with paclitaxel plus cisplatin: report of a case显示文摘Takafumi Watanabe Takaki Yoshikawa Yoichi Kameda Toru Aoyama Tsutomu Hayashi Takashi Ogata Haruhiko Cho Akira Tsuburaya Satoshi Morita Yumi Miyashita Junichi Sakamoto 2012Surgery Today2012,,10:1
8Involvement of reactive oxygen species in Microcystin-LR-induced cytogenotoxicity显示文摘Qingqing Nong Masaharu Komatsu Kimiko Izumo Hiroko P. Indo Baohui Xu Kohji Aoyama Hideyuki J. Majima Masahisa Horiuchi Kanehisa Morimoto Toru Takeuchi 2007Free Radical Research2007,,12:1
9Ankle brachial pressure index but not brachial-ankle pulse wave velocity is a strong predictor of systemic atherosclerotic morbidity and mortality in patients on maintenance hemodialysis显示文摘Miho Tanaka Hideki Ishii Toru Aoyama Hiroshi Takahashi Takanobu Toriyama Hirotake Kasuga Kyosuke Takeshita Daiji Yoshikawa Tetsuya Amano Toyoaki Murohara 2011Atherosclerosis2011,,2:1
10Priority of Lymph Node Dissection for Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction显示文摘Shinichi Hasegawa Takaki Yoshikawa Yasushi Rino Takashi Oshima Toru Aoyama Tsutomu Hayashi Tsutomu Sato Norio Yukawa Yoichi Kameda Takeshi Sasaki Hidetaka Ono Kazuhito Tsuchida Haruhiko Cho Chikara Kunisaki Munetaka Masuda Akira Tsuburaya 2013Annals of Surgical Oncology2013,,13:1
11Esophagus or Stomach? The Seventh TNM Classification for Siewert Type II/III Junctional Adenocarcinoma显示文摘Shinichi Hasegawa Takaki Yoshikawa Toru Aoyama Tsutomu Hayashi Takanobu Yamada Kazuhito Tsuchida Haruhiko Cho Takashi Oshima Norio Yukawa Yasushi Rino Munetaka Masuda Akira Tsuburaya 2013Annals of Surgical Oncology2013,,3:1
12Prognostic factors in stage IB gastric cancer显示文摘AIM:To identify the subset of patients with stage IB gastric cancer with an unfavorable prognosis.METHODS:Overall survival(OS)rates were examined in 103 patients with stage IB(T1N1M0 and T2N0M0)gastric cancer between January 2000 and December2011.Univariate and multivariate analyses were performed to identify risk factors using a Cox proportional hazards model.RESULTS:The OS rates of patients with T1N1 and T2N0 cancer were 89.2%and 94.1%at 5-years,re-spectively.Both univariate and multivariate analyses demonstrated that tumor location was the only significant prognostic factor.The OS rate was 81.8%at5-years when the tumor was located in the upper third of the stomach and was 95.5%at 5-years when the tumor was located in the middle or lower third of the stomach(P=0.0093).CONCLUSION:These data may suggest that tumor location is associated with survival in patients with stage IB gastric cancer.Toru Aoyama Takaki Yoshikawa Hirohito Fujikawa Tsutomu Hayashi Takashi Ogata Haruhiko Cho Takanobu Yamada Shinichi Hasegawa Kazuhito Tsuchida Norio Yukawa Takashi Oshima Mari S Oba Satoshi Morita Yasushi Rino Munetaka Masuda 2014World Journal of Gastroenterology2014,20,21:1
13Esophagus or Stomach? The Seventh TNM Classification for Siewert Type II/III Junctional Adenocarcinoma显示文摘Shinichi Hasegawa Takaki Yoshikawa Toru Aoyama Tsutomu Hayashi Takanobu Yamada Kazuhito Tsuchida Haruhiko Cho Takashi Oshima Norio Yukawa Yasushi Rino Munetaka Masuda Akira Tsuburaya 2013Annals of Surgical Oncology2013,,3:1
14Establishment of water distribution block system in OSAKA municipal waterworks 显示文摘Toru Aoyama Shinji Kawamoto 1999Water Supply1999,,17:1
15Factors predicting aggressiveness of non-hypervascular hepatic nodules detected on hepatobiliary phase of gadolinium ethoxybenzyl diethylene-triamine-pentaacetic-acid magnetic resonance imaging显示文摘AIM: To establish a prognostic formula that distinguishes non-hypervascular hepatic nodules(NHNs) with higher aggressiveness from less hazardous one. METHODS: Seventy-three NHNs were detected in gadolinium ethoxybenzyl diethylene-triamine-pentaaceticacid magnetic resonance imaging(Gd-EOB-DTPA-MRI) study and confirmed to change 2 mm or more in size and/or to gain hypervascularity. All images were interpreted independently by an experienced, board-certified abdominal radiologist and hepatologist; both knew thatthe patients were at risk for hepatocellular carcinoma development but were blinded to the clinical information. A formula predicting NHN destiny was developed using a generalized estimating equation model with thirteen explanatory variables: age, gender, background liver diseases, Child-Pugh class, NHN diameter, T1-weighted imaging/T2-weighted imaging detectability, fat deposition, lower signal intensity in arterial phase, lower signal intensity in equilibrium phase, α-fetoprotein, des-γ-carboxy prothrombin, α-fetoprotein-L3, and coexistence of classical hepatocellular carcinoma. The accuracy of the formula was validated in bootstrap samples that were created by resampling of 1000 iterations. RESULTS: During a median follow-up period of 504 d, 73 NHNs with a median diameter of 9 mm(interquartile range: 8-12 mm) grew or shrank by 68.5%(fifty nodules) or 20.5%(fifteen nodules), respectively, whereas hypervascularity developed in 38.4%(twenty eight nodules). In the fifteen shrank nodules, twelve nodules disappeared, while 11.0%(eight nodules) were stable in size but acquired vascularity. A generalized estimating equation analysis selected five explanatories from the thirteen variables as significant factors to predict NHN progression. The estimated regression coefficients were 0.36 for age, 6.51 for lower signal intensity in arterial phase, 8.70 or 6.03 for positivity of hepatitis B virus or hepatitis C virus, 9.37 for des-γ-carboxy prothrombin, and-4.05 for fat deposition. A formula incorporating the five coefficients revealed sensitivity, specificity, and accuracy of 88.0%, 86.7%, and 87.7% in the formulating cohort, whereas these of 87.2% ± 5.7%, 83.8% ± 13.6%, and 87.3% ± 4.5% in the bootstrap samples. CONCLUSION: These data suggest that the formula helps Gd-EOB-DTPA-MRI detect a trend toward hepatocyte transformation by predicting NHN destiny.Tsutomu Kanefuji Toru Takano Takeshi Suda Kouhei Akazawa Takeshi Yokoo Hiroteru Kamimura Kenya Kamimura Atsunori Tsuchiya Masaaki Takamura Hirokazu Kawai Satoshi Yamagiwa Hidefumi Aoyama Minoru Nomoto Shuji Terai 2015World Journal of Gastroenterology2015,21,15:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费